Show simple item record

Results of a trial of PET-directed therapy for early-stage Hodgkin's lymphoma.

dc.contributor.authorRadford, John A
dc.contributor.authorIllidge, Timothy M
dc.contributor.authorCounsell, N
dc.contributor.authorHancock, B
dc.contributor.authorPettengell, R
dc.contributor.authorJohnson, P
dc.contributor.authorWimperis, J
dc.contributor.authorCulligan, D
dc.contributor.authorPopova, B
dc.contributor.authorSmith, P
dc.contributor.authorMcMillan, A
dc.contributor.authorBrownell, A
dc.contributor.authorKruger, A
dc.contributor.authorLister, A
dc.contributor.authorHoskin, P
dc.contributor.authorO'Doherty, M
dc.contributor.authorBarrington, S
dc.date.accessioned2015-05-19T14:12:32Zen
dc.date.available2015-05-19T14:12:32Zen
dc.date.issued2015-04-23en
dc.identifier.citationResults of a trial of PET-directed therapy for early-stage Hodgkin's lymphoma. 2015, 372 (17):1598-607 N Engl J Meden
dc.identifier.issn1533-4406en
dc.identifier.pmid25901426en
dc.identifier.doi10.1056/NEJMoa1408648en
dc.identifier.urihttp://hdl.handle.net/10541/554169en
dc.description.abstractIt is unclear whether patients with early-stage Hodgkin's lymphoma and negative findings on positron-emission tomography (PET) after three cycles of chemotherapy with doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) require radiotherapy.
dc.language.isoenen
dc.rightsArchived with thanks to The New England journal of medicineen
dc.subject.meshAdolescenten
dc.subject.meshAdulten
dc.subject.meshAgeden
dc.subject.meshAntineoplastic Combined Chemotherapy Protocolsen
dc.subject.meshBleomycinen
dc.subject.meshCombined Modality Therapyen
dc.subject.meshDacarbazineen
dc.subject.meshDisease Progressionen
dc.subject.meshDoxorubicinen
dc.subject.meshFemaleen
dc.subject.meshFollow-Up Studiesen
dc.subject.meshHodgkin Diseaseen
dc.subject.meshHumansen
dc.subject.meshMaleen
dc.subject.meshMiddle Ageden
dc.subject.meshNeoplasm Stagingen
dc.subject.meshPositron-Emission Tomographyen
dc.subject.meshProportional Hazards Modelsen
dc.subject.meshRecurrenceen
dc.subject.meshSurvival Analysisen
dc.subject.meshVinblastineen
dc.subject.meshYoung Adulten
dc.titleResults of a trial of PET-directed therapy for early-stage Hodgkin's lymphoma.en
dc.typeArticleen
dc.contributor.departmentInstitute of Cancer Sciences, University of Manchester, and the Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchesteren
dc.identifier.journalThe New England Journal of Medicineen
dc.description.collectionLymphoma Research Teamen
html.description.abstractIt is unclear whether patients with early-stage Hodgkin's lymphoma and negative findings on positron-emission tomography (PET) after three cycles of chemotherapy with doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) require radiotherapy.


This item appears in the following Collection(s)

Show simple item record